These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5739595)

  • 21. [Sinobronchial syndrome].
    Courbot A; Chabot F; Jankowski R; Antunes L; Bene MC; Plenat F; Polu JM
    Rev Mal Respir; 2001 Apr; 18(2):193-6. PubMed ID: 11424716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bronchological methods of treating chronic suppurative lung diseases].
    Pribylova NN
    Sov Med; 1980; (12):78-80. PubMed ID: 7221724
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inhalative antimicrobial treatment of bronchiectasis].
    Schaberg T
    Pneumologie; 2004 Jul; 58(7):477-8. PubMed ID: 15257467
    [No Abstract]   [Full Text] [Related]  

  • 24. Managing bronchiectasis.
    Bradley J; Lavery K; Rendall J; Elborn JS
    Practitioner; 2006 Apr; 250(1681):194, 197, 199-200 passim. PubMed ID: 16669352
    [No Abstract]   [Full Text] [Related]  

  • 25. [Endobronchial instillations in suppurative bronchiectasis].
    MARTINEZ MARCHETTI A
    Rev Asoc Med Argent; 1954 May 15-30; 68(773-774):161-4. PubMed ID: 13204689
    [No Abstract]   [Full Text] [Related]  

  • 26. Quality of life and inflammation in exacerbations of bronchiectasis.
    Courtney JM; Kelly MG; Watt A; Garske L; Bradley J; Ennis M; Elborn JS
    Chron Respir Dis; 2008; 5(3):161-8. PubMed ID: 18684792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of conservative treatment of disseminated forms of chronic inflammatory-suppurative lung diseases].
    Alekseenko AV
    Ter Arkh; 1980; 52(1):57-9. PubMed ID: 7368125
    [No Abstract]   [Full Text] [Related]  

  • 28. [New approaches in antibiotic therapies in chronic pulmonary diseases].
    Celik U; Kocabas E
    Tuberk Toraks; 2008; 56(3):353-63. PubMed ID: 18932040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sensitivity of urinary pathogens to sulfonamides and antibiotics].
    SIEBER E; BANDMANN F
    Z Gesamte Inn Med; 1954 Jan; 9(1):26-30. PubMed ID: 13170203
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sulfonamides and antibiotics as a first therapeutic means in otorhinolaryngological acute diseases].
    VON OETTINGEN EN
    Med Monatsschr; 1954 May; 8(5):312-4. PubMed ID: 13193451
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic evaluation of hydromethyl associated with antibiotics and sulfonamides].
    CORSONELLO P
    Rass Int Clin Ter; 1954 Jun; 34(12):421-6. PubMed ID: 13194907
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of postoperative peritonitis by peroral use of sulfonamides and antibiotics].
    KURLOV VN
    Khirurgiia (Mosk); 1956 Nov; 32(11):21-5. PubMed ID: 13406939
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of antibiotics and their association with sulfonamides on the urethral microflora in non-gonorrheal urethritis in males].
    Soina KK
    Urol Nefrol (Mosk); 1965; 30(3):45-8. PubMed ID: 5861966
    [No Abstract]   [Full Text] [Related]  

  • 34. [Position on the problem of therapy of acute respiratory diseases with sulfonamides and antibiotics].
    Springfeld K
    Z Arztl Fortbild (Jena); 1983; 77(8):345-6. PubMed ID: 6868665
    [No Abstract]   [Full Text] [Related]  

  • 35. Problems related to the use of sulfonamides and antibiotics in the management of urinary tract infections.
    SPINK WW
    Postgrad Semin Am Urol Assoc North Cent; 1956-1957; ():153-60. PubMed ID: 13567661
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibiotics and sulfonamides in the treatment in acute inflammation of the biliary TRACT].
    Bialkowska J
    Pol Tyg Lek; 1966 Aug; 21(32):1240-3. PubMed ID: 5975404
    [No Abstract]   [Full Text] [Related]  

  • 37. [Medical therapy of empyema and bronchiectasis].
    MALANDRINO S
    Rass Clin Ter; 1953; 52(4):247-50. PubMed ID: 13145777
    [No Abstract]   [Full Text] [Related]  

  • 38. Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis.
    Chalmers JD; Keir HR
    Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34916253
    [No Abstract]   [Full Text] [Related]  

  • 39. Bronchiectasis exacerbations: certainties and future challenges.
    de la Rosa-Carrillo D; García-Clemente MM
    Int J Tuberc Lung Dis; 2022 Jul; 26(7):581-583. PubMed ID: 35768930
    [No Abstract]   [Full Text] [Related]  

  • 40. [Key points analysis of 2021 European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis].
    Ge A; Zhang YW; Xu JF
    Zhonghua Jie He He Hu Xi Za Zhi; 2021 Sep; 44(9):787-792. PubMed ID: 34496519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.